ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN)

CUSIP: 00654J107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / SPONSORED ADS
Total 13F shares
1,285,898
Share change
-268,018
Total reported value
$243,443
Price per share
$0.63
Number of holders
8
Value change
-$240,360
Number of buys
6
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 00654J107?
CUSIP 00654J107 identifies ADXN - ADDEX THERAPEUTICS LTD - SPONSORED ADS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN) as of Q4 2022

As of 31 Dec 2022, ADDEX THERAPEUTICS LTD - SPONSORED ADS (ADXN) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,285,898 shares. The largest 8 holders included NEA Management Company, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, OLD MISSION CAPITAL LLC, RENAISSANCE TECHNOLOGIES LLC, StoneX Group Inc., UBS Group AG, and Virtu Financial LLC. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.